Urgent Action Needed To End Tuberculosis By 2030, Concludes WHO’s Global Tuberculosis Report 14/10/2020 Svĕt Lustig Vijay The world must take urgent action to end the global tuberculosis epidemic by 2030, especially as the pandemic threatens to unwind hard-won progress made in past decades, concluded the WHO’s 2020 Global Tuberculosis Report on Wednesday. While the WHO European region is on track to achieve key 2020 targets, the rest of the world has […] Continue reading -> Johnson & Johnson ‘Pauses’ COVID-19 Vaccine Trial Due To Unexplained Illness In Participant; Eli Lilly Reportedly Suspending Trial Of Antibody Treatment 13/10/2020 Editorial team Illustration of the AdVac® adenovirus technology, being tested by Johnson & Johnson, (Credit: J&J) Johnson & Johnson, the only pharma firm currently developing a one-dose COVID-19 vaccine candidate, has “paused” its Phase 3 clinical trial due to an unexplained illness in one of the participants. A press release issued on Monday confirmed reports that a […] Continue reading -> China, Republic of Korea Join COVAX Global Vaccine Pool – WHO Urges Countries To Jumpstart Vaccine Campaigns 09/10/2020 Elaine Ruth Fletcher & Madeleine Hoecklin China has announced that it will join the WHO co-sponsored COVAX vaccine procurement pool, along with the Republic of Korea. WHO’s Director General Dr Tedros described it as a major boost to the global effort to manufacture and distribute 2 billion vaccines worldwide equitably by the end of 2021. “This week, China and the Republic […] Continue reading -> Moderna Makes Milestone Pledge To “Not Enforce Our Patents” On COVID-19 Vaccine Technologies During Pandemic & Issue Open Licenses Afterward 08/10/2020 Raisa Santos & Elaine Ruth Fletcher Moderna, Inc., developer of one of the four front-running COVID-19 vaccine candidates, announced on Thursday that the the company would “not enforce” its COVID-19-related patents against other companies making vaccines to combat the pandemic – and would also be willing to license intellectual property for their COVID-19 vaccines for the post pandemic period. “We feel […] Continue reading -> US Food and Drug Administration Issues New Rules Likely To Delay COVID-19 Vaccine Approval Until After Presidential Election 07/10/2020 Elaine Ruth Fletcher Acting on the advice of experts, the United States Food and Drug Administration on Tuesday issued new safety-focused guidelines for approval of new COVID-19 vaccines, that would almost certainly delay their emergency approval until after the November Presidential elections. Just hours after the rules were issued, United States President Donald Trump accused the FDA of […] Continue reading -> COVID-19 Vaccine Timeline Is Caught In “Crucible” of US Presidential Election – Pfizer CEO Protests 02/10/2020 Madeleine Hoecklin The CEO of Pfizer, one of the frontrunners in the race to develop a COVID-19 vaccine, has lambasted US President Donald Trump’s politicization of the vaccine approval timeline, declaring in an open letter that the company is “moving at the speed of science” and will not “succumb to political pressure” to prematurely rush its product […] Continue reading -> Moderna’s COVID-19 Vaccine Unlikely To Be Available To Public Before Spring, 2021; Initial US FDA Authorization Would Be Sought In Late November 01/10/2020 Madeleine Hoecklin Moderna intends to seek US Food and Drug Administration emergency authorization for its COVID-19 vaccine candidate for frontline medical workers by November 25th at the earliest, and only in late January for use in the general population. That means that the vaccine, if approved on schedule, would only be available for widespread distribution to the […] Continue reading -> World Bank Unleashes US$12 Billion in “Fast-Track” Finance For COVID-19 Vaccine Purchases By Low- And Middle-Income Countries 30/09/2020 Elaine Ruth Fletcher The World Bank will make available up to $12 billion in “fast-track financing” that low- and middle-income countries can access to procure vaccines against Covid-19 – as soon as one is approved, said the Bank’s president David Malpass, on Wednesday. The announcement at a United Nations high-level panel on the pandemic that also included commitments […] Continue reading -> WHO, The Pandemic And Europe’s New Global Health Leadership Role 29/09/2020 Elaine Ruth Fletcher Billions of dollars in vaccine investments are needed to beat back Covid-19. But on the bright side, Europe is playing a more active global health leadership role. Geneva’s ‘dean’ of global health speaks to Geneva Solutions ahead of Wednesday’s opening of the European Health Forum (Gastein), which brings together key policymakers and experts from across […] Continue reading -> World Health Organization Aims To Roll Out 120 Million COVID-19 Rapid Tests in Lower Income Countries – As COVID-19 Deaths Cross The 1 Million Mark 28/09/2020 Grace Ren Some 120 million COVID-19 rapid diagnostic tests will be made available to low and middle-income countries through the World Health Organization-hosted ACT Accelerator, an initiative to scale up COVID-19 drugs, diagnostics, and vaccines. The WHO Director-General Dr Tedros Adhanom Ghebreyesus made the announcement just before the world crossed the 1 million mark for deaths from […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Johnson & Johnson ‘Pauses’ COVID-19 Vaccine Trial Due To Unexplained Illness In Participant; Eli Lilly Reportedly Suspending Trial Of Antibody Treatment 13/10/2020 Editorial team Illustration of the AdVac® adenovirus technology, being tested by Johnson & Johnson, (Credit: J&J) Johnson & Johnson, the only pharma firm currently developing a one-dose COVID-19 vaccine candidate, has “paused” its Phase 3 clinical trial due to an unexplained illness in one of the participants. A press release issued on Monday confirmed reports that a […] Continue reading -> China, Republic of Korea Join COVAX Global Vaccine Pool – WHO Urges Countries To Jumpstart Vaccine Campaigns 09/10/2020 Elaine Ruth Fletcher & Madeleine Hoecklin China has announced that it will join the WHO co-sponsored COVAX vaccine procurement pool, along with the Republic of Korea. WHO’s Director General Dr Tedros described it as a major boost to the global effort to manufacture and distribute 2 billion vaccines worldwide equitably by the end of 2021. “This week, China and the Republic […] Continue reading -> Moderna Makes Milestone Pledge To “Not Enforce Our Patents” On COVID-19 Vaccine Technologies During Pandemic & Issue Open Licenses Afterward 08/10/2020 Raisa Santos & Elaine Ruth Fletcher Moderna, Inc., developer of one of the four front-running COVID-19 vaccine candidates, announced on Thursday that the the company would “not enforce” its COVID-19-related patents against other companies making vaccines to combat the pandemic – and would also be willing to license intellectual property for their COVID-19 vaccines for the post pandemic period. “We feel […] Continue reading -> US Food and Drug Administration Issues New Rules Likely To Delay COVID-19 Vaccine Approval Until After Presidential Election 07/10/2020 Elaine Ruth Fletcher Acting on the advice of experts, the United States Food and Drug Administration on Tuesday issued new safety-focused guidelines for approval of new COVID-19 vaccines, that would almost certainly delay their emergency approval until after the November Presidential elections. Just hours after the rules were issued, United States President Donald Trump accused the FDA of […] Continue reading -> COVID-19 Vaccine Timeline Is Caught In “Crucible” of US Presidential Election – Pfizer CEO Protests 02/10/2020 Madeleine Hoecklin The CEO of Pfizer, one of the frontrunners in the race to develop a COVID-19 vaccine, has lambasted US President Donald Trump’s politicization of the vaccine approval timeline, declaring in an open letter that the company is “moving at the speed of science” and will not “succumb to political pressure” to prematurely rush its product […] Continue reading -> Moderna’s COVID-19 Vaccine Unlikely To Be Available To Public Before Spring, 2021; Initial US FDA Authorization Would Be Sought In Late November 01/10/2020 Madeleine Hoecklin Moderna intends to seek US Food and Drug Administration emergency authorization for its COVID-19 vaccine candidate for frontline medical workers by November 25th at the earliest, and only in late January for use in the general population. That means that the vaccine, if approved on schedule, would only be available for widespread distribution to the […] Continue reading -> World Bank Unleashes US$12 Billion in “Fast-Track” Finance For COVID-19 Vaccine Purchases By Low- And Middle-Income Countries 30/09/2020 Elaine Ruth Fletcher The World Bank will make available up to $12 billion in “fast-track financing” that low- and middle-income countries can access to procure vaccines against Covid-19 – as soon as one is approved, said the Bank’s president David Malpass, on Wednesday. The announcement at a United Nations high-level panel on the pandemic that also included commitments […] Continue reading -> WHO, The Pandemic And Europe’s New Global Health Leadership Role 29/09/2020 Elaine Ruth Fletcher Billions of dollars in vaccine investments are needed to beat back Covid-19. But on the bright side, Europe is playing a more active global health leadership role. Geneva’s ‘dean’ of global health speaks to Geneva Solutions ahead of Wednesday’s opening of the European Health Forum (Gastein), which brings together key policymakers and experts from across […] Continue reading -> World Health Organization Aims To Roll Out 120 Million COVID-19 Rapid Tests in Lower Income Countries – As COVID-19 Deaths Cross The 1 Million Mark 28/09/2020 Grace Ren Some 120 million COVID-19 rapid diagnostic tests will be made available to low and middle-income countries through the World Health Organization-hosted ACT Accelerator, an initiative to scale up COVID-19 drugs, diagnostics, and vaccines. The WHO Director-General Dr Tedros Adhanom Ghebreyesus made the announcement just before the world crossed the 1 million mark for deaths from […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
China, Republic of Korea Join COVAX Global Vaccine Pool – WHO Urges Countries To Jumpstart Vaccine Campaigns 09/10/2020 Elaine Ruth Fletcher & Madeleine Hoecklin China has announced that it will join the WHO co-sponsored COVAX vaccine procurement pool, along with the Republic of Korea. WHO’s Director General Dr Tedros described it as a major boost to the global effort to manufacture and distribute 2 billion vaccines worldwide equitably by the end of 2021. “This week, China and the Republic […] Continue reading -> Moderna Makes Milestone Pledge To “Not Enforce Our Patents” On COVID-19 Vaccine Technologies During Pandemic & Issue Open Licenses Afterward 08/10/2020 Raisa Santos & Elaine Ruth Fletcher Moderna, Inc., developer of one of the four front-running COVID-19 vaccine candidates, announced on Thursday that the the company would “not enforce” its COVID-19-related patents against other companies making vaccines to combat the pandemic – and would also be willing to license intellectual property for their COVID-19 vaccines for the post pandemic period. “We feel […] Continue reading -> US Food and Drug Administration Issues New Rules Likely To Delay COVID-19 Vaccine Approval Until After Presidential Election 07/10/2020 Elaine Ruth Fletcher Acting on the advice of experts, the United States Food and Drug Administration on Tuesday issued new safety-focused guidelines for approval of new COVID-19 vaccines, that would almost certainly delay their emergency approval until after the November Presidential elections. Just hours after the rules were issued, United States President Donald Trump accused the FDA of […] Continue reading -> COVID-19 Vaccine Timeline Is Caught In “Crucible” of US Presidential Election – Pfizer CEO Protests 02/10/2020 Madeleine Hoecklin The CEO of Pfizer, one of the frontrunners in the race to develop a COVID-19 vaccine, has lambasted US President Donald Trump’s politicization of the vaccine approval timeline, declaring in an open letter that the company is “moving at the speed of science” and will not “succumb to political pressure” to prematurely rush its product […] Continue reading -> Moderna’s COVID-19 Vaccine Unlikely To Be Available To Public Before Spring, 2021; Initial US FDA Authorization Would Be Sought In Late November 01/10/2020 Madeleine Hoecklin Moderna intends to seek US Food and Drug Administration emergency authorization for its COVID-19 vaccine candidate for frontline medical workers by November 25th at the earliest, and only in late January for use in the general population. That means that the vaccine, if approved on schedule, would only be available for widespread distribution to the […] Continue reading -> World Bank Unleashes US$12 Billion in “Fast-Track” Finance For COVID-19 Vaccine Purchases By Low- And Middle-Income Countries 30/09/2020 Elaine Ruth Fletcher The World Bank will make available up to $12 billion in “fast-track financing” that low- and middle-income countries can access to procure vaccines against Covid-19 – as soon as one is approved, said the Bank’s president David Malpass, on Wednesday. The announcement at a United Nations high-level panel on the pandemic that also included commitments […] Continue reading -> WHO, The Pandemic And Europe’s New Global Health Leadership Role 29/09/2020 Elaine Ruth Fletcher Billions of dollars in vaccine investments are needed to beat back Covid-19. But on the bright side, Europe is playing a more active global health leadership role. Geneva’s ‘dean’ of global health speaks to Geneva Solutions ahead of Wednesday’s opening of the European Health Forum (Gastein), which brings together key policymakers and experts from across […] Continue reading -> World Health Organization Aims To Roll Out 120 Million COVID-19 Rapid Tests in Lower Income Countries – As COVID-19 Deaths Cross The 1 Million Mark 28/09/2020 Grace Ren Some 120 million COVID-19 rapid diagnostic tests will be made available to low and middle-income countries through the World Health Organization-hosted ACT Accelerator, an initiative to scale up COVID-19 drugs, diagnostics, and vaccines. The WHO Director-General Dr Tedros Adhanom Ghebreyesus made the announcement just before the world crossed the 1 million mark for deaths from […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Moderna Makes Milestone Pledge To “Not Enforce Our Patents” On COVID-19 Vaccine Technologies During Pandemic & Issue Open Licenses Afterward 08/10/2020 Raisa Santos & Elaine Ruth Fletcher Moderna, Inc., developer of one of the four front-running COVID-19 vaccine candidates, announced on Thursday that the the company would “not enforce” its COVID-19-related patents against other companies making vaccines to combat the pandemic – and would also be willing to license intellectual property for their COVID-19 vaccines for the post pandemic period. “We feel […] Continue reading -> US Food and Drug Administration Issues New Rules Likely To Delay COVID-19 Vaccine Approval Until After Presidential Election 07/10/2020 Elaine Ruth Fletcher Acting on the advice of experts, the United States Food and Drug Administration on Tuesday issued new safety-focused guidelines for approval of new COVID-19 vaccines, that would almost certainly delay their emergency approval until after the November Presidential elections. Just hours after the rules were issued, United States President Donald Trump accused the FDA of […] Continue reading -> COVID-19 Vaccine Timeline Is Caught In “Crucible” of US Presidential Election – Pfizer CEO Protests 02/10/2020 Madeleine Hoecklin The CEO of Pfizer, one of the frontrunners in the race to develop a COVID-19 vaccine, has lambasted US President Donald Trump’s politicization of the vaccine approval timeline, declaring in an open letter that the company is “moving at the speed of science” and will not “succumb to political pressure” to prematurely rush its product […] Continue reading -> Moderna’s COVID-19 Vaccine Unlikely To Be Available To Public Before Spring, 2021; Initial US FDA Authorization Would Be Sought In Late November 01/10/2020 Madeleine Hoecklin Moderna intends to seek US Food and Drug Administration emergency authorization for its COVID-19 vaccine candidate for frontline medical workers by November 25th at the earliest, and only in late January for use in the general population. That means that the vaccine, if approved on schedule, would only be available for widespread distribution to the […] Continue reading -> World Bank Unleashes US$12 Billion in “Fast-Track” Finance For COVID-19 Vaccine Purchases By Low- And Middle-Income Countries 30/09/2020 Elaine Ruth Fletcher The World Bank will make available up to $12 billion in “fast-track financing” that low- and middle-income countries can access to procure vaccines against Covid-19 – as soon as one is approved, said the Bank’s president David Malpass, on Wednesday. The announcement at a United Nations high-level panel on the pandemic that also included commitments […] Continue reading -> WHO, The Pandemic And Europe’s New Global Health Leadership Role 29/09/2020 Elaine Ruth Fletcher Billions of dollars in vaccine investments are needed to beat back Covid-19. But on the bright side, Europe is playing a more active global health leadership role. Geneva’s ‘dean’ of global health speaks to Geneva Solutions ahead of Wednesday’s opening of the European Health Forum (Gastein), which brings together key policymakers and experts from across […] Continue reading -> World Health Organization Aims To Roll Out 120 Million COVID-19 Rapid Tests in Lower Income Countries – As COVID-19 Deaths Cross The 1 Million Mark 28/09/2020 Grace Ren Some 120 million COVID-19 rapid diagnostic tests will be made available to low and middle-income countries through the World Health Organization-hosted ACT Accelerator, an initiative to scale up COVID-19 drugs, diagnostics, and vaccines. The WHO Director-General Dr Tedros Adhanom Ghebreyesus made the announcement just before the world crossed the 1 million mark for deaths from […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
US Food and Drug Administration Issues New Rules Likely To Delay COVID-19 Vaccine Approval Until After Presidential Election 07/10/2020 Elaine Ruth Fletcher Acting on the advice of experts, the United States Food and Drug Administration on Tuesday issued new safety-focused guidelines for approval of new COVID-19 vaccines, that would almost certainly delay their emergency approval until after the November Presidential elections. Just hours after the rules were issued, United States President Donald Trump accused the FDA of […] Continue reading -> COVID-19 Vaccine Timeline Is Caught In “Crucible” of US Presidential Election – Pfizer CEO Protests 02/10/2020 Madeleine Hoecklin The CEO of Pfizer, one of the frontrunners in the race to develop a COVID-19 vaccine, has lambasted US President Donald Trump’s politicization of the vaccine approval timeline, declaring in an open letter that the company is “moving at the speed of science” and will not “succumb to political pressure” to prematurely rush its product […] Continue reading -> Moderna’s COVID-19 Vaccine Unlikely To Be Available To Public Before Spring, 2021; Initial US FDA Authorization Would Be Sought In Late November 01/10/2020 Madeleine Hoecklin Moderna intends to seek US Food and Drug Administration emergency authorization for its COVID-19 vaccine candidate for frontline medical workers by November 25th at the earliest, and only in late January for use in the general population. That means that the vaccine, if approved on schedule, would only be available for widespread distribution to the […] Continue reading -> World Bank Unleashes US$12 Billion in “Fast-Track” Finance For COVID-19 Vaccine Purchases By Low- And Middle-Income Countries 30/09/2020 Elaine Ruth Fletcher The World Bank will make available up to $12 billion in “fast-track financing” that low- and middle-income countries can access to procure vaccines against Covid-19 – as soon as one is approved, said the Bank’s president David Malpass, on Wednesday. The announcement at a United Nations high-level panel on the pandemic that also included commitments […] Continue reading -> WHO, The Pandemic And Europe’s New Global Health Leadership Role 29/09/2020 Elaine Ruth Fletcher Billions of dollars in vaccine investments are needed to beat back Covid-19. But on the bright side, Europe is playing a more active global health leadership role. Geneva’s ‘dean’ of global health speaks to Geneva Solutions ahead of Wednesday’s opening of the European Health Forum (Gastein), which brings together key policymakers and experts from across […] Continue reading -> World Health Organization Aims To Roll Out 120 Million COVID-19 Rapid Tests in Lower Income Countries – As COVID-19 Deaths Cross The 1 Million Mark 28/09/2020 Grace Ren Some 120 million COVID-19 rapid diagnostic tests will be made available to low and middle-income countries through the World Health Organization-hosted ACT Accelerator, an initiative to scale up COVID-19 drugs, diagnostics, and vaccines. The WHO Director-General Dr Tedros Adhanom Ghebreyesus made the announcement just before the world crossed the 1 million mark for deaths from […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
COVID-19 Vaccine Timeline Is Caught In “Crucible” of US Presidential Election – Pfizer CEO Protests 02/10/2020 Madeleine Hoecklin The CEO of Pfizer, one of the frontrunners in the race to develop a COVID-19 vaccine, has lambasted US President Donald Trump’s politicization of the vaccine approval timeline, declaring in an open letter that the company is “moving at the speed of science” and will not “succumb to political pressure” to prematurely rush its product […] Continue reading -> Moderna’s COVID-19 Vaccine Unlikely To Be Available To Public Before Spring, 2021; Initial US FDA Authorization Would Be Sought In Late November 01/10/2020 Madeleine Hoecklin Moderna intends to seek US Food and Drug Administration emergency authorization for its COVID-19 vaccine candidate for frontline medical workers by November 25th at the earliest, and only in late January for use in the general population. That means that the vaccine, if approved on schedule, would only be available for widespread distribution to the […] Continue reading -> World Bank Unleashes US$12 Billion in “Fast-Track” Finance For COVID-19 Vaccine Purchases By Low- And Middle-Income Countries 30/09/2020 Elaine Ruth Fletcher The World Bank will make available up to $12 billion in “fast-track financing” that low- and middle-income countries can access to procure vaccines against Covid-19 – as soon as one is approved, said the Bank’s president David Malpass, on Wednesday. The announcement at a United Nations high-level panel on the pandemic that also included commitments […] Continue reading -> WHO, The Pandemic And Europe’s New Global Health Leadership Role 29/09/2020 Elaine Ruth Fletcher Billions of dollars in vaccine investments are needed to beat back Covid-19. But on the bright side, Europe is playing a more active global health leadership role. Geneva’s ‘dean’ of global health speaks to Geneva Solutions ahead of Wednesday’s opening of the European Health Forum (Gastein), which brings together key policymakers and experts from across […] Continue reading -> World Health Organization Aims To Roll Out 120 Million COVID-19 Rapid Tests in Lower Income Countries – As COVID-19 Deaths Cross The 1 Million Mark 28/09/2020 Grace Ren Some 120 million COVID-19 rapid diagnostic tests will be made available to low and middle-income countries through the World Health Organization-hosted ACT Accelerator, an initiative to scale up COVID-19 drugs, diagnostics, and vaccines. The WHO Director-General Dr Tedros Adhanom Ghebreyesus made the announcement just before the world crossed the 1 million mark for deaths from […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Moderna’s COVID-19 Vaccine Unlikely To Be Available To Public Before Spring, 2021; Initial US FDA Authorization Would Be Sought In Late November 01/10/2020 Madeleine Hoecklin Moderna intends to seek US Food and Drug Administration emergency authorization for its COVID-19 vaccine candidate for frontline medical workers by November 25th at the earliest, and only in late January for use in the general population. That means that the vaccine, if approved on schedule, would only be available for widespread distribution to the […] Continue reading -> World Bank Unleashes US$12 Billion in “Fast-Track” Finance For COVID-19 Vaccine Purchases By Low- And Middle-Income Countries 30/09/2020 Elaine Ruth Fletcher The World Bank will make available up to $12 billion in “fast-track financing” that low- and middle-income countries can access to procure vaccines against Covid-19 – as soon as one is approved, said the Bank’s president David Malpass, on Wednesday. The announcement at a United Nations high-level panel on the pandemic that also included commitments […] Continue reading -> WHO, The Pandemic And Europe’s New Global Health Leadership Role 29/09/2020 Elaine Ruth Fletcher Billions of dollars in vaccine investments are needed to beat back Covid-19. But on the bright side, Europe is playing a more active global health leadership role. Geneva’s ‘dean’ of global health speaks to Geneva Solutions ahead of Wednesday’s opening of the European Health Forum (Gastein), which brings together key policymakers and experts from across […] Continue reading -> World Health Organization Aims To Roll Out 120 Million COVID-19 Rapid Tests in Lower Income Countries – As COVID-19 Deaths Cross The 1 Million Mark 28/09/2020 Grace Ren Some 120 million COVID-19 rapid diagnostic tests will be made available to low and middle-income countries through the World Health Organization-hosted ACT Accelerator, an initiative to scale up COVID-19 drugs, diagnostics, and vaccines. The WHO Director-General Dr Tedros Adhanom Ghebreyesus made the announcement just before the world crossed the 1 million mark for deaths from […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
World Bank Unleashes US$12 Billion in “Fast-Track” Finance For COVID-19 Vaccine Purchases By Low- And Middle-Income Countries 30/09/2020 Elaine Ruth Fletcher The World Bank will make available up to $12 billion in “fast-track financing” that low- and middle-income countries can access to procure vaccines against Covid-19 – as soon as one is approved, said the Bank’s president David Malpass, on Wednesday. The announcement at a United Nations high-level panel on the pandemic that also included commitments […] Continue reading -> WHO, The Pandemic And Europe’s New Global Health Leadership Role 29/09/2020 Elaine Ruth Fletcher Billions of dollars in vaccine investments are needed to beat back Covid-19. But on the bright side, Europe is playing a more active global health leadership role. Geneva’s ‘dean’ of global health speaks to Geneva Solutions ahead of Wednesday’s opening of the European Health Forum (Gastein), which brings together key policymakers and experts from across […] Continue reading -> World Health Organization Aims To Roll Out 120 Million COVID-19 Rapid Tests in Lower Income Countries – As COVID-19 Deaths Cross The 1 Million Mark 28/09/2020 Grace Ren Some 120 million COVID-19 rapid diagnostic tests will be made available to low and middle-income countries through the World Health Organization-hosted ACT Accelerator, an initiative to scale up COVID-19 drugs, diagnostics, and vaccines. The WHO Director-General Dr Tedros Adhanom Ghebreyesus made the announcement just before the world crossed the 1 million mark for deaths from […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO, The Pandemic And Europe’s New Global Health Leadership Role 29/09/2020 Elaine Ruth Fletcher Billions of dollars in vaccine investments are needed to beat back Covid-19. But on the bright side, Europe is playing a more active global health leadership role. Geneva’s ‘dean’ of global health speaks to Geneva Solutions ahead of Wednesday’s opening of the European Health Forum (Gastein), which brings together key policymakers and experts from across […] Continue reading -> World Health Organization Aims To Roll Out 120 Million COVID-19 Rapid Tests in Lower Income Countries – As COVID-19 Deaths Cross The 1 Million Mark 28/09/2020 Grace Ren Some 120 million COVID-19 rapid diagnostic tests will be made available to low and middle-income countries through the World Health Organization-hosted ACT Accelerator, an initiative to scale up COVID-19 drugs, diagnostics, and vaccines. The WHO Director-General Dr Tedros Adhanom Ghebreyesus made the announcement just before the world crossed the 1 million mark for deaths from […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
World Health Organization Aims To Roll Out 120 Million COVID-19 Rapid Tests in Lower Income Countries – As COVID-19 Deaths Cross The 1 Million Mark 28/09/2020 Grace Ren Some 120 million COVID-19 rapid diagnostic tests will be made available to low and middle-income countries through the World Health Organization-hosted ACT Accelerator, an initiative to scale up COVID-19 drugs, diagnostics, and vaccines. The WHO Director-General Dr Tedros Adhanom Ghebreyesus made the announcement just before the world crossed the 1 million mark for deaths from […] Continue reading -> Posts navigation Older postsNewer posts